Literature DB >> 23205616

AD pathology and cerebral infarctions are associated with memory and executive functioning one and five years before death.

Frances M Yang1, Alexander Grigorenko, Doug Tommet, Sarah T Farias, Dan Mungas, David A Bennett, Richard N Jones, Paul K Crane.   

Abstract

We provide rigorous psychometric evidence for distinct patterns of cognitive impairment for Alzheimer's disease (AD) and cerebral infarctions using 440 participants from the Religious Order Study. Latent variable models were used to decompose the effects of AD pathology and cerebral infarctions assessed at autopsy on overall cognition and specific neuropsychological tests at one and five years prior to death. Results support clinical and univariate psychometric analyses that memory impairment is more pronounced in AD, and executive impairment is more pronounced in the presence of cerebral infarctions. These specific effects are subtle relative to the stronger associations of both AD neuropathology and cerebral infarctions with overall levels of cognitive impairment.

Entities:  

Mesh:

Year:  2012        PMID: 23205616      PMCID: PMC3605227          DOI: 10.1080/13803395.2012.740001

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  31 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Comparative fit indexes in structural models.

Authors:  P M Bentler
Journal:  Psychol Bull       Date:  1990-03       Impact factor: 17.737

3.  Relation of cerebral infarctions to dementia and cognitive function in older persons.

Authors:  J A Schneider; R S Wilson; E J Cochran; J L Bienias; S E Arnold; D A Evans; D A Bennett
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

Review 4.  Alzheimer's disease compared with cerebrovascular dementia. Neuropsychological similarities and differences.

Authors:  C Villardita
Journal:  Acta Neurol Scand       Date:  1993-04       Impact factor: 3.209

Review 5.  Advances in the early detection of Alzheimer's disease.

Authors:  Peter J Nestor; Philip Scheltens; John R Hodges
Journal:  Nat Med       Date:  2004-07       Impact factor: 53.440

6.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

7.  Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease.

Authors:  M Albert; L A Smith; P A Scherr; J O Taylor; D A Evans; H H Funkenstein
Journal:  Int J Neurosci       Date:  1991-04       Impact factor: 2.292

8.  Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.

Authors:  D A Bennett; R S Wilson; J A Schneider; D A Evans; N T Aggarwal; S E Arnold; E J Cochran; E Berry-Kravis; J L Bienias
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

9.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

10.  Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients.

Authors:  J A Cooper; H J Sagar; S M Doherty; N Jordan; P Tidswell; E V Sullivan
Journal:  Brain       Date:  1992-12       Impact factor: 13.501

View more
  6 in total

1.  Neuropsychological latent classes at enrollment and postmortem neuropathology.

Authors:  Andrea R Zammit; Charles B Hall; David A Bennett; Ali Ezzati; Mindy J Katz; Graciela Muniz-Terrera; Richard B Lipton
Journal:  Alzheimers Dement       Date:  2019-08-13       Impact factor: 21.566

Review 2.  A new era for dementia epidemiology: Alzheimer's disease, hardening of arteries, or just old age?

Authors:  Lewis H Kuller
Journal:  Eur J Epidemiol       Date:  2018-06-22       Impact factor: 8.082

Review 3.  Biomarker modelling of early molecular changes in Alzheimer's disease.

Authors:  Ross W Paterson; Jamie Toombs; Catherine F Slattery; Jonathan M Schott; Henrik Zetterberg
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

4.  Disentangling the effects of age and APOE on neuropathology and late life cognitive decline.

Authors:  Lei Yu; Patricia A Boyle; Sue Leurgans; Julie A Schneider; David A Bennett
Journal:  Neurobiol Aging       Date:  2013-10-09       Impact factor: 4.673

Review 5.  Religious Orders Study and Rush Memory and Aging Project.

Authors:  David A Bennett; Aron S Buchman; Patricia A Boyle; Lisa L Barnes; Robert S Wilson; Julie A Schneider
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Vitamin D and Vitamin K Concentrations in Human Brain Tissue Are Influenced by Freezer Storage Time: The Memory and Aging Project.

Authors:  Xueyan Fu; M Kyla Shea; Gregory G Dolnikowski; William B Patterson; Bess Dawson-Hughes; Thomas M Holland; Julie A Schneider; Sarah L Booth
Journal:  J Nutr       Date:  2021-01-04       Impact factor: 4.687

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.